Trichogenic effect of low level laser therapy combined with platelet-rich plasma for the management of androgenetic alopecia
Keywords:
androgenetic alopecia, low-level laser therapy, platelet-rich plasmaAbstract
Background: (AGA) is a very common hair disorder in men, Topical minoxidil and more recently low-level light therapy and Platelet-rich plasma therapy have been used in the management of (AGA). Objectives: To assess the Trichogenic effect of LLLT combined with PRP in the management of AGA. Patients and methods: Forty seven patients with AGAwere subjected to PRP therapy plus LLLT, affected area of all patients were treated for three months and then follow up for another three months. Efficacy was evaluated using global photography, folliscopic pictures analysis, answers for standardized hair growth questions and score of patient Gratification. Results: There was statistically significant improvement in diameter, vellus hair, terminal hair and density after treatment for three months although these improvements were decreased at three month after stoppage of treatment but still better than the baseline. Conclusion combination of LLLT with PRP could be a good treatment modality of AGA.
Downloads
References
Galadari H, Shivakumar S, Lotti T, et al. Low-level laser therapy and narrative review of other treatment modalities in Androgenetic alopecia. Lasers Med Sci. 2020. https://doi.org/10.1007/s10103-020-02994-4.
Goren A, Sharma A, Dhurat R, et al. Low-dose daily aspirin reduces topical Minoxidil efficacy in Androgenetic alopecia patients. Dermatol Ther. 2018; 31(6):e12741. doi: 10.1111/dth.12741.
Yi Y, Qiu J, Jia J, et al. Severity of Androgenetic alopecia associated with poor sleeping habits and carnivorous eating and junk food consumption—a web-based investigation of male pattern hair loss in China. Dermatol Ther. 2020; 14:e13273. doi: 10.1111/dth.13273.
Fields JR, Vonu PM, Monir RL, Schoch JJ. Topical ketoconazole for the treatment of Androgenetic alopecia: a systematic review. Dermatol Ther. 2020; 33(1):e13202. doi: 10.1111/dth.13202.
Olsen EA. Female pattern hair loss. J Am Acad Dermatol. 2001; 45:S70-80. doi: 10.1067/mjd.2001.117426.
Ramos PM, Santos LDN, Mesinkovska NA, Goren A, Miot HA. Can we halt male Androgenetic alopecia progression without ant androgenic drugs? Dermatol Ther. 2020; 33(1):e13197. PMID: 31846191 DOI: 10.1111/dth.13197.
Blumeyer A, Tosti A, Messenger A, Reygagne P, Del Marmol V, Spuls PI, TrakatelliM, Finner A, Kiesewetter F, Trüeb R, Rzany B. Evidence‐based (S3) guideline for the treatment of Androgenetic alopecia in women and in men. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2011 Oct; 9:S1- 57.PMID: 21980982 DOI: 10.1111/j.1610-0379.2011.07802.x
Kim WS, Calderhead RG. Is light-emitting diode phototherapy (LED-LLLT) really effective? Laser Ther.2011; 20:205–15. doi: 10.5978/islsm.20.205
Avci P, Gupta GK, Clark J, et al. Low-Level Laser (Light) Therapy (LLLT) for Treatment of Hair Loss.
Lasers Surg Med. 2013; 9999:1. PMID: 23970445 PMCID: PMC3944668 DOI: 10.1002/lsm.22170
Suchonwanit P, Chalermroj N, Khunkhet S. Low-level laser therapy for the treatment of Androgenetic alopecia in Thai men and women: a 24-week, randomized, double-blind, sham device controlled trial. Lasers Med Sci 2019 Aug; 34(6):1107-1114 doi: 10.1007/s10103-018-02699-9. Epub 2018 Dec 19.
Lanzafame RJ, Blanche RR, Chiacchierini RP, et al. The growth of human scalp hair in females using visible red-light laser and LED sources. Lasers Surg Med. 2014; 46:601–7. doi: 10.1002/lsm.22277
Gentile P, Calabrese C, De Angelis B, et al. Impact of the Different Preparation Methods to Obtain Autologous Non-Activated Platelet-Rich Plasma (A-PRP) and Activated Platelet-Rich Plasma (AA-PRP) in Plastic Surgery: Wound Healing and Hair Regrowth Evaluation. Int J Mol Sci. 2020; 9:21(2). doi: 10.3390/ijms21020431
Stevens J, Khetarpal S. Platelet-rich plasma for Androgenetic alopecia: a review of the literature and proposed treatment protocol. Int J Women’s Dermatol 2019; 5(1):46–51. doi:10.1016/j.ijwd.2018.08.004.
Gupta M, Mysore V. Classifications of patterned hair loss: a review. Journal of cutaneous and aestheticsurgery. 2016 Jan; 9(1):3. PMID: 27081243 PMCID: PMC4812885 DOI: 10.4103/0974-2077.178536
Verma K, Tegta GR, Verma G, Gupta M, Negi A, Sharma R. A study to compare the efficacy of platelet rich plasma and Minoxidil therapy for the treatment of Androgenetic alopecia. Int j Trichology. 2019 Mar; 11(2):68.
PMID: 31007475PMCID: PMC6463452 DOI: 10.4103/ijt.ijt_64_18
Otberg N, Finner AM, Shapiro J. Androgenetic alopecia. Endocrinol Metab Clin North Am. 2007; 36(2):379–398. PMID: 17543725 DOI: 10.1016/j.ecl.2007.03.004
Ghanaat M. Types of hair loss and treatment options, including the novel low-level light therapy and its proposed mechanism. South Med J. 2010; 103(9):917–921. PMID: 20689478 DOI: 10.1097/SMJ.0b013e3181ebcf71
Itami S, Inui S. Role of androgen in mesenchymal epithelial interactions in human hair follicle. J Investig Dermatol Symp Proc. 2005; 10(3):209–211. PMID: 16382666 DOI: 10.1111/j.1087-0024.2005.10107.x
Hoffmann R, Happle R. Current understanding of Androgenetic alopecia. Part I: Etiopathogenesis. Eur J Dermatol. 2000; 10(4):319–327. PMID: 10846263
Rogers NE, Avram MR. Medical treatments for male and female pattern hair loss. J Am Acad Dermatol. 2008; 59(4):547–566. Quiz 567–548. PMID: 18793935.DOI: 10.1016/j.jaad.2008.07.001
Darwin E, Heyes A, Hirt PA, Wikramanayake TC, Jimenez JJ. Low-level laser therapy for the treatment of androgenic alopecia: a review. Lasers Med Sci. 2018 Feb; 33(2):425-434. doi: 10.1007/s10103-017-2385-5. Epub 2017 Dec 21. PMID: 29270707.
Marwah M, Godse K, Patil S, Nadkarni N: Is there sufficient research data to use platelet rich plasma in dermatology? Int J Trichology 2014; 6: 35–36.PMID: 25114455 PMCID: PMC4124695 DOI: 10.4103/0974- 7753.136763
Dhillon RS, Schwarz EM, Maloney MD: Platelet-rich plasma therapy – future or trend? Arthritis Res Ther 2012; 14: 21PMID: 22894643PMCID: PMC3580559 DOI: 10.1186/ar3914
Gentile P, Dionisi L, Pizzicannella J, de Angelis B, de Fazio D, Garcovich S. A randomized blinded retrospective study: the combined use of micro-needling technique, low-level laser therapy and autologous non- activated platelet-rich plasma improves hair re-growth in patients with androgenic alopecia. Expert Opin Biol Ther. 2020 Sep; 20(9):1099-1109. doi: 10.1080/14712598.2020.1797676. Epub 2020 Jul 27. PMID: 32678725.
Lubart R, Eichler M, Lavi R, Friedman H, Shainberg A. Low energy laser irradiation promotes cellular redox activity. Photomed Laser Surg. 2005; 23(1):3–9. PMID: 15782024 DOI: 10.1089/pho.2005.23.3
Eells JT, Wong-Riley MT, Ver Hoeve J, Henry M, Buchman EV, Kane MP, et al. Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy. Mitochondrion.2004; 4(5– 6):559–67.PMID: 16120414 DOI: 10.1016/j.mito.2004.07.033
Pastore D, Greco M, Passarella S. Specific helium-neon laser sensitivity of the purified cytochrome c oxidase. Int J Radiat Biol.2000; 76(6):863–70.PMID: 10902741DOI: 10.1080/09553000050029020
Arany PR, Nayak RS, Hallikerimath S, Limaye AM, Kale AD, Kondaiah P. Activation of latent TGF- beta1 by low-power laser in vitro correlates with increased TGF-beta1 levels in laser enhanced oral wound healing.
Wound Repair Regen. 2007; 15(6):866–74. PMID: 18028135 DOI: 10.1111/j.1524-475X.2007.00306.x
de Lima FM, Villaverde AB, Albertini R, Correa JC, Carvalho RL, Munin E, et al. Dual effect of low-level laser therapy (LLLT) on the acute lung inflammation induced by intestinal ischemia and reperfusion: action on anti- and pro-inflammatory cytokines. Lasers Surg Med. 2011; 43(5):410–20. PMID: 21674546 DOI: 10.1002/lsm.21053
Jaworsky C, Kligman AM, Murphy GF. Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis. Br J Dermatol. 1992; 127(3):239–46. PMID: 1390168 DOI: 10.1111/j.1365-2133.1992.tb00121.x
Mafra de Lima F, Villaverde AB, Salgado MA, Castro-Faria-Neto HC, Munin E, Albertini R, et al. Low intensity laser therapy (LLL-T) in vivo acts on the Neutrophils recruitment and Chemokines/ cytokines levels in a model of acute pulmonary inflammation induced by aerosol of lipopolysaccharide from Escherichia coli in rat. J Photochem Photobiol B. 2010; 101(3): 271–8. PMID: 20728373 DOI: 10.1016/j.jphotobiol.2010.07.012
Magro CM, Rossi A, Poe J, Manhas-Bhutani S, Sadick N. The role of inflammation and immunity in the pathogenesis of Androgenetic alopecia. J Drugs Dermatol. 2011; 10(12):1404–11. PMID: 22134564
Sakurai Y, Yamaguchi M, Abiko Y. Inhibitory effect of low-level laser irradiation on LPS-stimulated prostaglandin E2 production and cyclooxygenase-2 in human gingival fibroblasts. Eur J Oral Sci. 2000; 108(1):29– 34. PMID: 10706474 DOI: 10.1034/j.1600-0722.2000.00783.x
Akiyama M, Smith LT, Holbrook KA: Growth factor and growth factor receptor localization in the hair follicle bulge and associated tissue in human fetus. J Invest Dermatol 1996; 106: 391–396. PMID: 8648166 DOI: 10.1111/1523-1747.ep12343381
Gkini M-A, Kouskoukis A-E, Tripsianis G, Rigopoulos D, Kouskoukis K: Study of platelet-rich plasma injections in the treatment of Androgenetic alopecia through a one-year period. J Cutan Aesthet Surg 2014; 7: 213– 219. PMID: 25722600 PMCID: PMC4338465, doi: 10.4103/0974-2077.150743
Cervelli V, Garcovich S, Bielli A, Cervelli G, Curcio BC, Scioli MG, Orlandi A, Gentile P:The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histo Morphometric evaluation. Biomed Res Int 2014; 2014: 760709.
Gentile P, Cole JP, Cole MA, et al. Evaluation of Not-Activated and Activated PRP in Hair Loss Treatment: Role of Growth Factor and Cytokine Concentrations Obtained by Different Collection Systems. Int.J. Mol. Sci. 2017;18: 408. PMID: 28216604 PMCID: PMC5343942, doi: 10.3390/ijms18020408
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
